Biohal's mission is to create a universally available preventive medicine platform that runs on blockchain with liquid biopsy protocol. By joining hands with PROTEO, the first liquid biopsy research partner, Biohal can detect cancer and alzheimers at early stages. With minimally invasive markers, Biohal's test accuracy remains at 99%.
Started decentralized medical blockchain project
Started to develop Demo app with Bio medical protocol
BIOHAL ICO Launched
Bio Authentication Dapp(β）
Establish the new Liquid Biopsy Labs
Release BIOHAL Open Network(α)